Ibrahim, Lobna <br/><br/>
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  May 2012 
 - 1526-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1740-634X 
<br/><br/><label>Standard No.: </label>10.1038/npp.2011.338  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Depression--drug therapy<br/>Double-Blind Method<br/>Excitatory Amino Acid Antagonists--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous--methods<br/>Ketamine--administration & dosage<br/>Male<br/>Middle Aged<br/>Outcome Assessment, Health Care<br/>Psychiatric Status Rating Scales<br/>Riluzole--therapeutic use<br/>Time Factors<br/>Young Adult